Paula Goodman Fraenkel

Global Clinical Program Lead, Late Development Oncology @AstraZeneca

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2024 — Present

Global Clinical Program Lead, Late Development Oncology @AstraZeneca

View department →

Clinical lead for several global Phase 3 clinical trials in NSCLC, including CDP development, planning, study design, execution, and filing for registration. Experience working with corporate alliances and biomarker development.

EDUCATION

N/A

Harvard University

Bachelor's Degree, Biology

N/A

Harvard Medical School

Doctor of Medicine (M.D.)

ABOUT PAULA GOODMAN FRAENKEL

Experienced physician scientist with a demonstrated history of working in the hospital & health care industry. Skilled in Translational Research, Clinical Research, Animal Models, Medical Education, Hematology and Oncology. Strong research and development professional with a medical degree from Harvard University.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Paula Goodman Fraenkel — Global Clinical Program Lead, Late Development Oncology at AstraZeneca in Boston, MA, US | Unifers